Eberhard Meier

779 total citations
8 papers, 494 citations indexed

About

Eberhard Meier is a scholar working on Surgery, Epidemiology and Dermatology. According to data from OpenAlex, Eberhard Meier has authored 8 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Epidemiology and 3 papers in Dermatology. Recurrent topics in Eberhard Meier's work include Helicobacter pylori-related gastroenterology studies (4 papers), Microscopic Colitis (3 papers) and Hidradenitis Suppurativa and Treatments (3 papers). Eberhard Meier is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (4 papers), Microscopic Colitis (3 papers) and Hidradenitis Suppurativa and Treatments (3 papers). Eberhard Meier collaborates with scholars based in Germany, Switzerland and United States. Eberhard Meier's co-authors include Manfred Stolte, B Bethke, Stephan Miehlke, Elke Bästlein, E. Bayerdörffer, Norbert Lehn, Peter Heymer, Ahmed Madisch, J. Delarive and A Tromm and has published in prestigious journals such as Gastroenterology, Alimentary Pharmacology & Therapeutics and International Journal of Colorectal Disease.

In The Last Decade

Eberhard Meier

8 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eberhard Meier Germany	7	326	224	223	190	128	8	494
Louis Zetzel United States	10	231 0.7×	240 1.1×	166 0.7×	12 0.1×	32 0.3×	19	402
G Walker United Kingdom	7	135 0.4×	185 0.8×	96 0.4×	10 0.1×	29 0.2×	26	256
Shashi Prakash Mishra India	8	106 0.3×	13 0.1×	201 0.9×	12 0.1×	41 0.3×	25	302
Emmanuel Gizard France	5	143 0.4×	169 0.8×	297 1.3×	5 0.0×	90 0.7×	5	422
Lara Aguilera Spain	8	60 0.2×	48 0.2×	168 0.8×	5 0.0×	54 0.4×	21	240
Tedesco Fj	8	147 0.5×	17 0.1×	163 0.7×	6 0.0×	113 0.9×	12	352
Sharma Mp India	11	46 0.1×	28 0.1×	204 0.9×	5 0.0×	56 0.4×	33	310
J E Laberenne France	4	147 0.5×	200 0.9×	120 0.5×	3 0.0×	27 0.2×	6	268
Marta Ruiz de Valbuena Spain	7	43 0.1×	32 0.1×	109 0.5×	4 0.0×	45 0.4×	12	188
Anja Bruns Germany	7	80 0.2×	18 0.1×	387 1.7×	11 0.1×	9 0.1×	11	429

Countries citing papers authored by Eberhard Meier

Since Specialization

Citations

This map shows the geographic impact of Eberhard Meier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eberhard Meier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eberhard Meier more than expected).

Fields of papers citing papers by Eberhard Meier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eberhard Meier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eberhard Meier. The network helps show where Eberhard Meier may publish in the future.

Co-authorship network of co-authors of Eberhard Meier

This figure shows the co-authorship network connecting the top 25 collaborators of Eberhard Meier. A scholar is included among the top collaborators of Eberhard Meier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eberhard Meier. Eberhard Meier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Kruis, Wolfgang, Eberhard Meier, M. Schumacher, et al.. (2013). Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon – a placebo‐controlled study. Alimentary Pharmacology & Therapeutics. 37(7). 680–690. 60 indexed citations

Miehlke, Stephan, Ahmed Madisch, B Bethke, et al.. (2008). Oral Budesonide for Maintenance Treatment of Collagenous Colitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Gastroenterology. 135(5). 1510–1516. 101 indexed citations

Antoš, David, Wulf Schneider‐Brachert, Elke Bästlein, et al.. (2006). 7‐Day Triple Therapy of Helicobacter pylori Infection with Levofloxacin, Amoxicillin, and High‐Dose Esomeprazole in Patients with Known Antimicrobial Sensitivity. Helicobacter. 11(1). 39–45. 67 indexed citations

Meier, Eberhard, et al.. (2005). Effects of pantoprazole 20 mg in mildgastroesophageal reflux disease: Once-daily treatment in the acute phase, and comparison of on-demand versus continuous treatment in the long term. Current Therapeutic Research. 66(4). 345–363. 16 indexed citations

Madisch, Ahmed, Peter Heymer, B Wigginghaus, et al.. (2004). Oral budesonide therapy improves quality of life in patients with collagenous colitis. International Journal of Colorectal Disease. 20(4). 312–316. 64 indexed citations

Madisch, Ahmed, Wulf Schneider‐Brachert, Michael Büchner, et al.. (2003). 7-day triple therapy with esomeprazole, levefloxacin and amoxycillin is effective in patients with metronidazole- and clarithromycin-sensitive and -resistant H. pylori strains. Gastroenterology. 124(4). A102–A102. 2 indexed citations

Miehlke, Stephan, Peter Heymer, B Bethke, et al.. (2002). Budesonide treatment for collagenous colitis: A randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology. 123(4). 978–984. 164 indexed citations

Stolte, M., Eberhard Meier, & Alexander Meining. (1998). Cure of autoimmune gastritis by Helicobacter pylori eradication in a 21-year-old male.. PubMed. 36(8). 641–3. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact